The NIH has created the NIH StrokeNet to conduct small and large clinical trials and research studies to advance acute stroke treatment, stroke prevention, and recovery and rehabilitation following a stroke. This network of 25 regional centers across the U.S., which involves more than 200 hospitals, is designed to serve as the infrastructure and pipeline for exciting new potential treatments for patients with stroke and those at risk for stroke. In addition, NIH StrokeNet will provide an educational platform for stroke physicians and clinical trial coordinators.
In September 2013, the National Institutes of Health funded the stroke trials network, NIH StrokeNet. The StrokeNet infrastructure consists of 25 regional coordinating centers across the US, a national coordinating center at the University of Cincinnati, and a national data management center (Medical University of South Carolina). The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery.
Save Your Spot -
Registration for ESOC is now open! If you register early, you can save up to €160.
ESO Members can profit from an even higher reduced registration fee as well as many other benefits. -
Early Registration Deadline: 13 March 2018
Abstract Submission opens December 15, 2017 and closes February 9, 2018 -
Posters are being accepted for categories of:
Clinical Care Best Practice,
The ACRM Conference: Progress in Rehabilitation Research brings together an inter-professional mix of rehabilitation professionals from around the world to learn about cutting-edge research and its translation into clinical practice to improve the quality of life experienced by people with disabilities
The 4th European Stroke Organisation Conference (ESOC 2018) will facilitate learning, discussion, and exchange among European and international stroke specialists. Guided by the motto “The Voice of Stroke in Europe,” at the Conference you will learn about the latest clinical trials and developments in all areas of stroke management, treatment and prevention.
Not only will this leading conference enhance your knowledge and practice, it will provide you with a unique opportunity to network with a wide range of professionals in the field of stroke.
Join us in Gothenburg on 16-18 May 2018.
The World Stroke Organization (WSO) is theWSO LOGO full.jpg world’s
leading organization in the fight against stroke. It was established in October 2006 through the merger of the International Stroke Society and the World Stroke Federation with the purpose of constituting one world voice for stroke. Today, WSO has more than 2,600 individual members and over 60 society members from 85 different countries.
Lead the way to discovery in the fight against stroke by submitting your best science to this
exceptional educational event dedicated to the science and treatment of cerebrovascular disease.
The International Stroke Conference is the world's premiere stroke meeting and an ideal forum for communicating your research to stroke specialists from around the world - from the most basic research to patient-based studies to larger clinical trials. Submit your science and be a part of this exceptional and illuminating experience!
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
This FOA encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions, as well as biomarker-or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery. Successful applicants will collaborate and conduct the trial within the NIH StrokeNet. Following peer review, NINDS will prioritize trials among the highest scoring to be conducted in the NIH StrokeNet infrastructure.
NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose exploratory and confirmatory clinical trials focused on promising interventions, as well as biomarker-or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery. The program will utilize the cooperative agreement mechanism to enable milestone-drive projects.
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke
Treatment, Recovery, and Prevention Infrastructure Resource
This FOA encourages requests for access to research resources for multi-site exploratory and confirmatory clinical trials focused on promising interventions, as well as biomarker-or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery. Successful applicants will be given access to the NIH StrokeNet infrastructure.
previous daynext daytoday
NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General Hospital NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General HospitalNIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke.
Treatments for acute stroke include IV t-PA, stroke centers, stroke units, endovascular thrombectomy devices for selected patients, nimodipine for subarachnoid hemorrhage, and aneurysm coiling and clipping for ruptured aneurysms. Intracerebral hemorrhage has proven to be the most challenging for effective treatments; however recent research has shown promise
Despite the advances made in acute stroke care, stroke remains the leading cause of adult disability in Americans. World-wide there is an estimated 50 million stroke survivors coping with significant physical, cognitive and emotional deficits. The field of stroke recovery and restorative neuroscience is still young and provides a rich environment for innovative trials.